NextRX Inc.

NextRX Inc. logo via Clearbit

Profile

According to their SEC filings, NextRX Inc. is a Corporation organized in NV on 09-01-2015. They report having 2 employee(s), and revenue in their most-recent fiscal year of $0.00 and $0.00 the prior year.

Company Description

"NextRx is currently working on their newest project, the RxPass. The RxPass will revolutionize the way medical marijuana patients access their medication."

Website: http://www.nextrx.net

Sector: Information Technology

Industry: Internet Software & Services

Twitter: NextRx

LinkedIn: nextrx-inc-

Location

8670 WEST CHEYENNE AVENUE

SUITE 120

LAS VEGAS, NV 89129

Equity Crowdfunding Campaigns

Reg CF Offering from NextRX Inc. (Previous)

Campaign Details

According to their SEC filings, NextRX Inc. previously ran a Regulation Crowdfunding campaign to raise $20,000.00 (up to a maximum of $100,000.00) in Common Stock via truCrowd, Inc before a deadline of 04-20-2018.

As compensation for managing the offering, truCrowd, Inc reported being compensated as follows:

The intermediary will get paid 8% success fee.

In addition to any direct compensation, NextRX Inc. reported that truCrowd, Inc would also receive the following financial interest in the offering:

None

NextRX Inc. filed the following progress report with the SEC at the end of their campaign:

The campaign was closed on 4/20/2018 and raised $29,402 from 38 investors.

Reg CF Offering from NextRX Inc. (Previous)

Campaign Details

According to their SEC filings, NextRX Inc. previously ran a Regulation Crowdfunding campaign to raise $80,000.00 (up to a maximum of $100,000.00) in Common Stock via StartEngine before a deadline of 06-06-2016.

As compensation for managing the offering, StartEngine reported being compensated as follows:

A flat fee of 7% if the campaign is successful

In addition to any direct compensation, NextRX Inc. reported that StartEngine would also receive the following financial interest in the offering:

No

More information about this issuer may also be available via Crowditz.com, including information about weekly and aggregate investor commitments.

Financial Information

The following information is taken directly from SEC filings.

Income Statement Items

Most Recent Fiscal Year Prior Fiscal Year
Revenue $0.00 $0.00
Cost of Goods Sold $0.00 $0.00
Taxes Paid $2,392.00 $0.00
Net Income $-102,832.00 $-48,127.00

Balance Sheet Items

Most Recent Fiscal Year Prior Fiscal Year
Total Assets $0.00 $0.00
Cash and Cash Equivalents $3,877.00 $27,303.00
Accounts Receivable $0.00 $0.00
Short-term Debt $0.00 $0.00
Long-term Debt $92,150.00 $63,799.00

Complete Reg CF filings list for NextRX Inc.

  • [2018-05-15T20:54:42+00:00] NextRX Inc. filed a fundraising progress report (Form C-U) with the following update: ""

    File number: 020-23169

  • [2018-01-16T17:41:34+00:00] NextRX Inc. filed an amended Form C (Form C/A) regarding their offering to raise a target of $20,000.00 via truCrowd, Inc. The nature of the amendment was described as follows:

    Extended the campaign until 4/16/2018

    File number: 020-23169

  • [2017-11-21T19:11:32+00:00] NextRX Inc. filed an amended Form C (Form C/A) regarding their offering to raise a target of $20,000.00 via truCrowd, Inc. The nature of the amendment was described as follows:

    Extended the campaign until 1/16/2018

    File number: 020-23169

  • [2017-08-28T15:09:56+00:00] NextRX Inc. filed an amended Form C (Form C/A) regarding their offering to raise a target of $20,000.00 via truCrowd, Inc. The nature of the amendment was described as follows:

    Extended the campaign until 11/24/2017.

    File number: 020-23169

  • [2017-07-28T19:17:53+00:00] NextRX Inc. filed an amended Form C (Form C/A) regarding their offering to raise a target of $20,000.00 via truCrowd, Inc. The nature of the amendment was described as follows:

    Extended the campaign until 8/31/2017 and corrected the price per share from $5 to $2 to match the info provided via the funding portal.

    File number: 020-23169

  • [2017-06-27T19:32:59+00:00] NextRX Inc. filed an amended Form C (Form C/A) regarding their offering to raise a target of $20,000.00 via truCrowd, Inc. The nature of the amendment was described as follows:

    Extended campaign

    File number: 020-23169

  • [2017-04-19T17:53:39+00:00] NextRX Inc. filed an amended Form C (Form C/A) regarding their offering to raise a target of $20,000.00 via truCrowd, Inc. The nature of the amendment was described as follows:

    Extended campaign

    File number: 020-23169

  • [2017-02-28T13:33:22+00:00] NextRX Inc. filed an amended Form C (Form C/A) regarding their offering to raise a target of $20,000.00 via truCrowd, Inc. The nature of the amendment was described as follows:

    Extended expiration date to 4/20/2017

    File number: 020-23169

  • [2017-02-27T18:11:09+00:00] NextRX Inc. filed an amended Form C (Form C/A) regarding their offering to raise a target of $20,000.00 via truCrowd, Inc. The nature of the amendment was described as follows:

    Updated valuation and change in price per share

    File number: 020-23169

  • [2017-01-24T12:59:13+00:00] NextRX Inc. filed an amended Form C (Form C/A) regarding their offering to raise a target of $20,000.00 via truCrowd, Inc. The nature of the amendment was described as follows:

    Updated valuation and change in price per share

    File number: 020-23169

  • New Filing Form C

    [2017-01-17T20:29:49+00:00] NextRX Inc. filed a Form C to raise a target amount of $20,000.00 (up to a maximum of $100,000.00) of via truCrowd, Inc.

    File number: 020-23169

  • New Filing Form C

    [2016-05-16T12:26:46+00:00] NextRX Inc. filed a Form C to raise a target amount of $80,000.00 (up to a maximum of $100,000.00) of via StartEngine.

    File number: 020-22835